Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

cancer immunotherapy

  • You have access
    Cytotoxicity of Human Hepatic Intrasinusoidal Gamma/Delta T Cells Depends on Phospho-antigen and NK Receptor Signaling
    YOORHA KANG, MINA HAN, MINSONG KIM, HYUN JU HWANG, BYUNG CHAN AHN, EUNYOUNG TAK, GI-WON SONG, SHIN HWANG, KYUNG-NAM KOH, DONG-HWAN JUNG and NAYOUNG KIM
    Anticancer Research January 2023, 43 (1) 63-73; DOI: https://doi.org/10.21873/anticanres.16135
  • You have access
    Heat Shock Protein 105 as an Immunotherapeutic Target for Patients With Cervical Cancer
    KAZUTO NOSAKA, SHIRO SUZUKI, TOSHIAKI YOSHIKAWA, MANAMI SHIMOMURA, KAZUHISA KITAMI, KOSUKE YOSHIDA, MASATO YOSHIHARA, FUMITAKA KIKKAWA, TETSUYA NAKATSURA and HIROAKI KAJIYAMA
    Anticancer Research October 2021, 41 (10) 4741-4751; DOI: https://doi.org/10.21873/anticanres.15289
  • You have access
    Cytokine-based Cancer Immunotherapy: Challenges and Opportunities for IL-10
    KATHRINE S. RALLIS, AMBER E. CORRIGAN, HASHIM DADAH, ALAN MATHEW GEORGE, SUMIRAT M. KESHWARA, MICHAIL SIDERIS and BERNADETT SZABADOS
    Anticancer Research July 2021, 41 (7) 3247-3252; DOI: https://doi.org/10.21873/anticanres.15110
  • You have access
    T-cell-based Immunotherapies for Haematological Cancers, Part A: A SWOT Analysis of Immune Checkpoint Inhibitors (ICIs) and Bispecific T-Cell Engagers (BiTEs)
    KATHRINE S. RALLIS, CHRISTOPHER R.T. HILLYAR, MICHAIL SIDERIS and JEFF K. DAVIES
    Anticancer Research March 2021, 41 (3) 1123-1141; DOI: https://doi.org/10.21873/anticanres.14870
  • You have access
    T-cell-based Immunotherapies for Haematological Cancers, Part B: A SWOT Analysis of Adoptive Cell Therapies
    KATHRINE S. RALLIS, CHRISTOPHER R.T. HILLYAR, MICHAIL SIDERIS and JEFF K. DAVIES
    Anticancer Research March 2021, 41 (3) 1143-1156; DOI: https://doi.org/10.21873/anticanres.14871
  • You have access
    Therapeutic Time-restricted Feeding Reduces Renal Tumor Bioluminescence in Mice but Fails to Improve Anti-CTLA-4 Efficacy
    WILLIAM J. TURBITT, RACHAEL M. ORLANDELLA, JUSTIN T. GIBSON, COURTNEY M. PETERSON and LYSE A. NORIAN
    Anticancer Research October 2020, 40 (10) 5445-5456; DOI: https://doi.org/10.21873/anticanres.14555
  • You have access
    Expression of Immune Checkpoint Receptors on T-Cells and Their Ligands on Leukemia Blasts in Childhood Acute Leukemia
    SUNG HAN KANG, HYUN JU HWANG, JAE WON YOO, HYERY KIM, EUN SEOK CHOI, SANG-HYUN HWANG, YOUNG-UK CHO, SEONGSOO JANG, CHAN-JEOUNG PARK, HO JOON IM, JONG JIN SEO, NAYOUNG KIM and KYUNG-NAM KOH
    Anticancer Research October 2019, 39 (10) 5531-5539; DOI: https://doi.org/10.21873/anticanres.13746
  • You have access
    Safety Evaluation of Autologous Tissue Vaccine Cancer Immunotherapy in a Canine Model
    RACHEL A. CROSSLEY, ALYSSA MATZ, TERRY DEW, ASHLEY KALINAUSKAS, NICOLE FAUCETTE, BRAD POFF, LAWRENCE K. SILBART and MARK A. SUCKOW
    Anticancer Research April 2019, 39 (4) 1699-1703; DOI: https://doi.org/10.21873/anticanres.13275
  • You have access
    Mismatch Repair Protein Deficiency Is a Risk Factor for Aberrant Expression of HLA Class I Molecules: A Putative “Adaptive Immune Escape” Phenomenon
    TERUFUMI KUBO, YOSHIHIKO HIROHASHI, KAZUHIKO MATSUO, TOMOKO SONODA, HIROKI SAKAMOTO, KIYOSHI FURUMURA, TOMOHIDE TSUKAHARA, TAKAYUKI KANASEKI, MUNEHIDE NAKATSUGAWA, HIROSHI HIRANO, TOMOHISA FURUHATA, ICHIRO TAKEMASA, TADASHI HASEGAWA and TOSHIHIKO TORIGOE
    Anticancer Research March 2017, 37 (3) 1289-1295;
  • You have access
    Sugar-carrying Polystyrenes Facilitate Harvesting of APCs from MLRs: Possible Application of Sugar-carrying Polystyrenes to Immunotherapy
    AKIRA IMAIZUMI, HIDEYA ONISHI, AKIO YAMASAKI, MAKOTO KAWAMOTO, TAKASHI MORISAKI, MITSUAKI GOTO, MASAMICHI IWAMA, TOSHIHIRO AKAIKE and KENICHIRO HASUMI
    Anticancer Research February 2016, 36 (2) 673-676;

Pages

  • Next
  • 1
  • 2
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire